Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.Astex gets IND approval for cancer drug
This is the third IND candidate from Astex’s internal discovery and development programmes to be approved. Astex plans to begin clinical trials of AT13387 in cancer patients during
This is the third IND candidate from Astex’s internal discovery and development programmes to be approved. Astex plans to begin clinical trials of AT13387 in cancer patients during
In the intent-to-treat cohort in the study after 90 days, the tested therapeutic dose of NX-1207 had a mean BPH (benign prostatic hyperplasia) symptom score improvement of 9.71
The agreement includes $123 million in upfront and potential development milestone payments from Kyowa to ArQule, of which ArQule previously received a $30 million cash licensing payment. The
Currently aimed at developing and manufacturing mammalian cell culture-based products, the expansion means Cook Pharmica also will offer formulation, filling and finishing services to customers. The facility will
Novo Nordisk continues to fully fund Neose’s development work for Factor VIII. The company is also working with Novo Nordisk under separate license agreements to develop long-acting, GlycoPEGylated
The newly licensed myokines include a novel secreted protein named NK102 which has demonstrated significant blood glucose reductions when administered to obese animals. Other licensed proteins include NK110
The primary objectives of the study are to assess the safety and tolerability of intravenous infusions of CD-NP in patients with heart failure. Safety assessments include measurement of
As part of the agreement BioWisdom will join the InforSense Open Workflow Partner Network. Michael Stapleton, chief business officer of BioWisdom, said: “SRS provides a specialist healthcare search
The unique patient programmer used with the RestoreULTRA system gives patients more control over their therapy than ever before. In addition, the RestoreULTRA neurostimulator allows patients who use
Neutrolin is a liquid that locks a patient’s central venous catheter (CVC) between hemodialysis (HD) sessions to keep it free of infection and clots. Bruce Cooper, president and